Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Rejoni

company

About

Rejoni develops solutions designed to minimize the short and long-term risks associated with gynecological procedures.

Details

Last Funding Type
Series B
Last Funding Money Raised
$25M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical Device
Founded date
Jun 1, 2020
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Rejoni, Inc.

Rejoni develops solutions designed to minimize the short and long-term risks associated with gynecological procedures. It is working on developing solutions that minimize both acute and chronic risks associated with gynecologic procedures by providing women’s health-centered technologies that help women to achieve the life they want both now and in the future.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$40M
Rejoni has raised a total of $40M in funding over 2 rounds. Their latest funding was raised on Dec 7, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 7, 2022 Series B $25M 6 Catalyst Health Ventures Detail
Sep 14, 2020 Series A $15M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
6
Rejoni is funded by 6 investors. Catalyst Health Ventures and AMED Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Catalyst Health Ventures Yes Series B
AMED Ventures Series B
Ascension Ventures Series B
Delos Capital Series B
Iyengar Capital Partners Series B
Sparta Group Series B

Employee Profiles

Number of Employee Profiles
3
Rejoni has 3 current employee profiles, including Executive Amarpreet Sawhney
Executive
Board member
Board member